Previous Hold Today XLRN ranks #1664 as HOLD CANDIDATE. Next Hold
Today XLRN ranks #1664 as HOLD CANDIDATE.

XLRN stock Acceleron Pharma Inc.

XLRN stock
Acceleron Pharma Inc.

March 25, 2019
Change 1.63%
Chart period: 2018-12-26 - 2019-03-25
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Will XLRN stock price go up or down on Tue, 26 Mar 2019?

Acceleron Pharma Inc. Forecast and Stock Analysis

Technical XLRN stock analysis for March 25, 2019.

Hold candidate since 2019-03-25
Shorts n/a
Cash n/a
Loans n/a
Beta 1.40
ROA -33.77

Acceleron Pharma Inc. gained 1.63% in the last trading day, rising from $44.16 to $44.88 The price has fallen in 6 of the last 10 days and is down by -3.23% for this period. Volume fell in the last day by -106 599 shares, and in total, 228 787 shares bought and sold for approximately $10.27 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Monday, 25th Mar 2019) of the XLRN stock was $44.88. This is 1.63% more than the trading day before Friday, 22nd Mar 2019.

During day the stock fluctuated 3.99% from a day low at $43.39 to a day high of $45.12.

30 day high of the XLRN stock price was $47.98 and low was $41.39.
90 day high was $48.57 and low was $38.42.
52 week high for the Acceleron Pharma Inc. - $59.59 and low - $32.53.

Trend

Acceleron Pharma Inc. lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.56% during the next 3 months and, with 90% probability hold a price between $43.05 and $53.05 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Acceleron Pharma Inc. holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $45.95. On a fall, the stock will find some support from the long-term average at approximately $44.34. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Friday March 22, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Thursday March 21, 2019 and based on theory for this formation the price should fall by -3.40% to $43.73 within 4 trading days since signal was issued (Wednesday March 27, 2019).

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acceleron Pharma Inc. finds support from accumulated volume at $42.81.

Support: $42.81 Price: $44.88 Resistance: $45.16

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.73 (3.99%) between high and low. For the last week, the stock has had a daily average volatility of 4.86%.

Our recommended stoploss: $42.50 (-5.31%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Hold/Accumulate

Acceleron Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Previous Hold Today XLRN ranks #1664 as HOLD CANDIDATE. Next Hold
Today XLRN ranks #1664 as HOLD CANDIDATE.